Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.70
+0.56 (2.23%)
Aug 29, 2025, 4:00 PM - Market closed
Fresenius Medical Care AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 19,518 | 19,336 | 19,454 | 19,398 | 17,619 | 17,859 | Upgrade | |
Revenue Growth (YoY) | 0.53% | -0.60% | 0.29% | 10.10% | -1.35% | 2.19% | Upgrade |
Cost of Revenue | 14,703 | 14,579 | 14,529 | 14,504 | 12,846 | 12,322 | Upgrade |
Gross Profit | 4,815 | 4,757 | 4,925 | 4,894 | 4,773 | 5,537 | Upgrade |
Selling, General & Admin | 3,138 | 3,143 | 3,196 | 3,170 | 2,773 | 2,966 | Upgrade |
Research & Development | 171.71 | 183.49 | 231.97 | 228.62 | 220.78 | 193.77 | Upgrade |
Other Operating Expenses | -75.8 | -109.03 | -26.86 | -43.25 | -124.41 | - | Upgrade |
Operating Expenses | 3,234 | 3,217 | 3,401 | 3,356 | 2,869 | 3,160 | Upgrade |
Operating Income | 1,581 | 1,539 | 1,524 | 1,538 | 1,904 | 2,378 | Upgrade |
Interest Expense | -392.41 | -407.04 | -424.64 | -360.14 | -353.6 | -409.98 | Upgrade |
Interest & Investment Income | 75 | 71.58 | 88.22 | 67.66 | 73.17 | 41.96 | Upgrade |
Earnings From Equity Investments | 166.4 | 134.88 | 121.79 | 66.56 | 92.18 | 94.52 | Upgrade |
Currency Exchange Gain (Loss) | -33.05 | -23.06 | -35.5 | -36.83 | -9.9 | - | Upgrade |
EBT Excluding Unusual Items | 1,397 | 1,316 | 1,273 | 1,275 | 1,706 | 2,104 | Upgrade |
Merger & Restructuring Charges | -175.47 | -317.48 | -259.92 | -147.95 | -37.55 | - | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -193.98 | Upgrade |
Gain (Loss) on Sale of Investments | -74.7 | 44.03 | 14.67 | 44.85 | -87.63 | - | Upgrade |
Gain (Loss) on Sale of Assets | 14.51 | 14.66 | 4.84 | 47.17 | -8.63 | - | Upgrade |
Asset Writedown | - | - | - | - | - | -3.25 | Upgrade |
Other Unusual Items | - | - | - | - | - | 29.41 | Upgrade |
Pretax Income | 1,161 | 1,057 | 1,033 | 1,219 | 1,572 | 1,936 | Upgrade |
Income Tax Expense | 316.84 | 316.06 | 300.56 | 324.95 | 352.83 | 500.56 | Upgrade |
Earnings From Continuing Operations | 844.01 | 740.87 | 732.46 | 894.33 | 1,219 | 1,436 | Upgrade |
Minority Interest in Earnings | -187.6 | -202.96 | -233.46 | -220.92 | -249.72 | -271.46 | Upgrade |
Net Income | 656.42 | 537.91 | 499 | 673.41 | 969.31 | 1,164 | Upgrade |
Net Income to Common | 656.42 | 537.91 | 499 | 673.41 | 969.31 | 1,164 | Upgrade |
Net Income Growth | 23.79% | 7.80% | -25.90% | -30.53% | -16.75% | -2.94% | Upgrade |
Shares Outstanding (Basic) | 293 | 293 | 293 | 293 | 293 | 294 | Upgrade |
Shares Outstanding (Diluted) | 293 | 293 | 293 | 293 | 293 | 294 | Upgrade |
Shares Change (YoY) | - | - | 0.06% | 0.06% | -0.41% | -2.80% | Upgrade |
EPS (Basic) | 2.24 | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | Upgrade |
EPS (Diluted) | 2.23 | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | Upgrade |
EPS Growth | 23.39% | 7.65% | -25.97% | -30.60% | -16.44% | -0.01% | Upgrade |
Free Cash Flow | 2,048 | 1,687 | 1,944 | 1,443 | 1,635 | 3,181 | Upgrade |
Free Cash Flow Per Share | 6.98 | 5.75 | 6.63 | 4.92 | 5.58 | 10.81 | Upgrade |
Dividend Per Share | 1.440 | 1.440 | 1.190 | 1.120 | 1.350 | 1.340 | Upgrade |
Dividend Growth | 21.01% | 21.01% | 6.25% | -17.04% | 0.75% | 11.67% | Upgrade |
Gross Margin | 24.67% | 24.60% | 25.32% | 25.23% | 27.09% | 31.01% | Upgrade |
Operating Margin | 8.10% | 7.96% | 7.83% | 7.93% | 10.81% | 13.31% | Upgrade |
Profit Margin | 3.36% | 2.78% | 2.56% | 3.47% | 5.50% | 6.52% | Upgrade |
Free Cash Flow Margin | 10.49% | 8.72% | 9.99% | 7.44% | 9.28% | 17.81% | Upgrade |
EBITDA | 2,361 | 2,347 | 2,379 | 2,512 | 2,799 | 3,261 | Upgrade |
EBITDA Margin | 12.10% | 12.14% | 12.23% | 12.95% | 15.88% | 18.26% | Upgrade |
D&A For EBITDA | 780.2 | 807.31 | 855.58 | 973.66 | 894.89 | 882.87 | Upgrade |
EBIT | 1,581 | 1,539 | 1,524 | 1,538 | 1,904 | 2,378 | Upgrade |
EBIT Margin | 8.10% | 7.96% | 7.83% | 7.93% | 10.81% | 13.31% | Upgrade |
Effective Tax Rate | 27.29% | 29.90% | 29.09% | 26.65% | 22.45% | 25.85% | Upgrade |
Revenue as Reported | 19,518 | 19,336 | 19,454 | 19,398 | 17,619 | 17,859 | Upgrade |
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.